Allegiant Rx News
RxWIRE Newsletter – January 5, 2017
Donald Trump promised voters an immediate repeal of Obamacare, but Republicans in Congress likely won't have a bill ready for him on Day One. Or Day Two. Or perhaps even his first two weeks.
Read MoreRxWIRE Newsletter – December 29, 2017
On April 26, an FDA advisory committee voted 7-6 that the exon-skipping drug eteplirsen for Duchenne muscular dystrophy (DMD) failed to meet the standards needed for accelerated approval.
Read MoreRxWIRE Newsletter – December 22, 2016
We won't surprise anyone by saying that Topic No. 1 in pharma this year was drug pricing. We'll give you one guess as to whether 2017 will be more of the same.
Read MoreRxWIRE Newsletter – December 15, 2016
The financial future of pharmacy benefit managers is uncertain as payers, legislators and regulators focus on rising drug prices, according to Moody's Investors Service.
Read More